Early levosimendan administration may improve outcome in patients with subarachnoid hemorrhage complicated by acute heart failure

International Journal of Cardiology

Volumn 176, Issue 3, 2014, Pages 1435-1437

  Papanikolaou, John ^a   Tsolaki, Vasiliki ^a   Makris, Demosthenes ^a   Zakynthinos, Epaminondas ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

Acute heart failure; Cardiogenic shock; Levosimendan; Neurogenic stress cardiomyopathy; Outcome; Subarachnoid hemorrhage

Indexed keywords

CARDIOTONIC AGENT; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN;

ACUTE DISEASE; ADULT; CASE REPORT; COMPLICATION; DOSE RESPONSE; DRUG EFFECTS; FEMALE; HEART CONTRACTION; HEART FAILURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY; SUBARACHNOID HEMORRHAGE; TIME;

ACUTE DISEASE; ADULT; CARDIOTONIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART FAILURE; HUMANS; HYDRAZONES; INJECTIONS, INTRAVENOUS; MYOCARDIAL CONTRACTION; PYRIDAZINES; SUBARACHNOID HEMORRHAGE; TIME FACTORS;

EID: 84908243717     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.08.039     Document Type: Article

References (10)

1. K.A. Bybee, and A. Prasad Stress-related cardiomyopathy syndromes Circulation 118 4 2008 397 409
2. S.J. Huang, and A.S. McLean Appreciating the strengths and weaknesses of transthoracic echocardiography in hemodynamic assessments Cardiol Res Pract 2012 2012 894308
3. J. Papanikolaou, D. Makris, and D. Karakitsos Cardiac and central vascular functional alterations in the acute phase of aneurysmal subarachnoid hemorrhage Crit Care Med 40 2012 223 232
4. S.A. Mayer, J. Lin, and S. Homma Myocardial injury and left ventricular performance after subarachnoid hemorrhage Stroke 30 4 1999 780 786
5. Van der Bilt, D. Hasan, and R. van der Brink Cardiac dysfunction after aneurismal subarachnoid hemorrhage: relationship with outcome Neurology 82 4 2014 351 358
6. M. Joseph, S. Ziadi, J. Nates, M. Dannenbaum, and M. Malkoff Increases in cardiac output can reverse flow deficits from vasospasm independent of blood pressure: a study using xenon computed tomographic measurement of cerebral blood flow Neurosurgery 53 5 2003 1044 1051
7. J. Lilleberg, M. Laine, T. Palkama, M. Kivikko, P. Pohjanjousi, and M. Kupari Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure Eur J Heart Fail 9 1 2007 75 82
8. S.L. Cengiz, M.F. Erdi, and M. Tosun Beneficial effects of levosimendan on cerebral vasospasm induced by subarachnoid haemorrhage: an experimental study Brain Inj 24 6 2010 877 885
9. M. Hein, N. Zoremba, C. Bleilevens, C. Bruells, R. Rossaint, and A.B. Roehl Levosimendan limits reperfusion injury in a rat middle cerebral artery occlusion (MCAO) model BMC Neurol 13 1 2013 106
10. F.S. Taccone, A. Brasseur, J.L. Vincent, and D. De Backer Levosimendan for the treatment of subarachnoid hemorrhage-related cardiogenic shock Intensive Care Med 39 8 2013 1497 1498